Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Ultragenyx Pharmaceutical Company Profile (NASDAQ:RARE)

Consensus Ratings for Ultragenyx Pharmaceutical (NASDAQ:RARE) (?)
Ratings Breakdown: 8 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $74.63 (19.23% upside)

Analysts' Ratings History for Ultragenyx Pharmaceutical (NASDAQ:RARE)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/31/2015WedbushInitiated CoverageOutperform$74.00ViewTweet This Rating  Share This Rating on StockTwits
3/30/2015MLV & Co.Initiated CoverageBuy$79.00ViewTweet This Rating  Share This Rating on StockTwits
3/26/2015Canaccord GenuityReiterated RatingBuy$68.00ViewTweet This Rating  Share This Rating on StockTwits
3/26/2015JPMorgan Chase & Co.Reiterated RatingOverweight$66.00ViewTweet This Rating  Share This Rating on StockTwits
3/24/2015CRT CapitalInitiated CoverageBuy$90.00ViewTweet This Rating  Share This Rating on StockTwits
3/16/2015Canaccord GenuityBoost Price TargetBuy$62.00 -> $68.00ViewTweet This Rating  Share This Rating on StockTwits
2/11/2015Canaccord GenuitySet Price TargetBuy$62.00ViewTweet This Rating  Share This Rating on StockTwits
1/13/2015JPMorgan Chase & Co.Reiterated RatingOverweightViewTweet This Rating  Share This Rating on StockTwits
1/8/2015Canaccord GenuityInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
10/16/2014SunTrustInitiated CoverageBuy$82.00ViewTweet This Rating  Share This Rating on StockTwits
9/23/2014Jefferies GroupInitiated CoverageBuy$74.00ViewTweet This Rating  Share This Rating on StockTwits
7/15/2014Robert W. BairdInitiated CoverageOutperform$64.00ViewTweet This Rating  Share This Rating on StockTwits
2/25/2014Cowen and CompanyInitiated CoverageOutperformViewTweet This Rating  Share This Rating on StockTwits
2/25/2014Morgan StanleyInitiated CoverageOverweight$81.00ViewTweet This Rating  Share This Rating on StockTwits
2/25/2014Canaccord GenuityInitiated CoverageBuy$85.00ViewTweet This Rating  Share This Rating on StockTwits
2/25/2014JPMorgan Chase & Co.Initiated CoverageOverweight$66.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/20/2013 forward)